| Financial Year |
March 31 2023 |
| Monetary Funds |
1,220,376,050.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
93,951,391.96 |
| Accounts Receivable |
1,872,274,907.70 |
| Advances to Suppliers |
217,716,950.85 |
| Other Receivables |
77,165,853.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,748,033,231.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,412,490.35 |
| Total Current Assets |
7,405,742,119.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
185,657,869.32 |
| Investment Properties |
75,565,008.19 |
| Fixed Assetes |
215,307,394.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,760,342.27 |
| R&D expenses |
8,175,229.45 |
| Goodwill |
8,315,672.80 |
| Long-Term Deferred and Prepaid Expenses |
17,105,019.17 |
| Deferred Income Tax Assets |
50,375,409.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
936,951,105.32 |
| Total Assets |
8,342,693,224.58 |
| Short-Term Loans |
242,081,787.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
876,256,555.29 |
| Accounts Payable |
1,107,423,577.98 |
| Accounts Received In Advance |
611,158.20 |
| Employee Compensation Payable |
43,473,019.42 |
| Taxes Payable |
32,098,242.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
138,846,796.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,400,553.71 |
| Other Current Liabilities |
21,108,901.19 |
| Sub-Total of Current Liabilities |
4,789,513,758.63 |
| Long-term Loans |
1,023,969,919.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,999,513.41 |
| Deferred Income Tax Liabilities |
14,108,132.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,074,688,438.72 |
| Total Liabilities |
5,864,202,197.35 |
| Paid-In Capital(Or Share Stock) |
394,360,697.00 |
| Capital Surplus |
1,358,443,343.15 |
| Surplus Reserve |
106,952,972.05 |
| LESS:Treasury Stock |
101,865,554.40 |
| Undistributed Profits |
665,373,309.70 |
| Minority Stockholder's Interest |
53,367,689.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,425,123,337.77 |
| Owner's Equity（Stockholder's Equity） |
2,478,491,027.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,342,693,224.58 |
